REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women
Iron deficiency anemia (IDA) during pregnancy arises because of preexisting inadequate stores or complex physiological changes and can lead to serious maternal and fetal complications. Oral iron, either as iron sulfate or fumarate, with or without folic acid, is the most commonly used treatment for...
Saved in:
Main Authors: | Saleema Wani, Mariyam Noushad, Shabana Ashiq |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Anemia |
Online Access: | http://dx.doi.org/10.1155/2019/4640635 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
by: Melvin H. Seid, et al.
Published: (2017-01-01) -
Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
by: Iftikhar Hussain, et al.
Published: (2013-01-01) -
Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnancy: A Subgroup Analysis of a Multicenter Real-World Study Involving 1191 Pregnant Women
by: Prakash Trivedi, et al.
Published: (2022-01-01) -
Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study
by: Anouk Pels, et al.
Published: (2015-01-01) -
Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice
by: António Robalo Nunes, et al.
Published: (2017-01-01)